Donovan William Dean 4

4 · Controladora Vuela Compania de Aviacion, S.A.B. de C.V. · Filed Apr 28, 2026

AI-generated summary of this filing

Updated Apr 28, 2026

Vuela (VLRS) Director Donovan Dean Exercises RSUs, Disposes 232,400 ADSs

What Happened

Donovan William Dean, a director of Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (VLRS), had derivative awards (RSUs) convert/exercise on April 28, 2026 into 232,400 ADS-equivalent shares (transaction code M). The same filing shows two disposition entries on April 28, 2026 totaling 232,400 shares (111,550 and 120,850).
On April 24, 2026 Dean was granted two RSU awards of 59,260 and 64,200 RSUs (transaction code A) at $0.00; those RSUs are derivative awards (no cash cost). The April 28 conversion likely relates to earlier RSUs that vested; reported dollar prices/proceeds are either N/A or $0.00 in the Form 4, so no cash value is reported in this filing.

Key Details

Transaction dates: Grants on 2026-04-24; conversion/exercise and dispositions on 2026-04-28.
Prices/values reported: Grants listed at $0.00; one acquisition entry shows price N/A; disposition entries list $0.00 — the filing does not report cash proceeds.
Shares reported: 232,400 shares converted/exercised and 232,400 shares disposed (111,550 + 120,850).
Ownership after transaction: Not specified in the provided filing data.
Relevant footnotes: F1—RSUs granted 4/28/2025 vested 4/28/2026; F4—RSUs granted 4/24/2026 vest 4/24/2027; F3—each RSU represents a contingent right to one Series A share; F2—shares are held as ADSs (each ADS represents 10 CPOs, each CPO an economic interest in one Series A share).
Filing timeliness: Form filed 2026-04-28 for transactions through 2026-04-28 (no late filing indicated).
Exhibit: Exhibit 24 — Power of Attorney included.

Context

RSUs are derivative awards that convert to underlying shares upon vesting. This filing shows conversion of vested RSUs (exercise/conversion) and matching dispositions on the same date, which is commonly how insiders monetize vested awards, but the Form 4 here does not report cash proceeds.
Because these are director RSU conversions and grants (not open-market purchases), they are typically award/compensation- and vesting-driven rather than a direct signal of personal bullish purchases. Watch future filings for any reported sale proceeds or additional insider purchases.

Form 4

Period: 2026-04-24

Director

Transactions

Exercise/Conversion
Series A shares of common stock
[F1][F2][F3]
2026-04-28+232,400→ 3,096,050 total
Award
Restricted Securities Units (Annual Fee)
[F3][F4]
2026-04-24+59,260→ 59,260 total
→ Series A shares of common stock (59,260 underlying)
Award
Restricted Securities Units (BoDIP)
[F3][F4]
2026-04-24+64,200→ 64,200 total
→ Series A shares of common stock (64,200 underlying)
Exercise/Conversion
Restricted Securities Units (Annual Fee)
[F3][F1]
2026-04-28−111,550→ 0 total
→ Series A shares of common stock (111,550 underlying)
Exercise/Conversion
Restricted Securities Units (BoDIP)
[F3][F1]
2026-04-28−120,850→ 0 total
→ Series A shares of common stock (106,461 underlying)

Footnotes (4)

[F1]The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date.
[F2]Shares owned through American Depositary Shares ("ADSs"). Each ADS representing ten (10) Certificados de Participacion Ordinarios (CPOs). Each CPO representing the economic interest in one (1) share of Series A shares of common stock.
[F3]Each RSU represents a contingent right to receive on Series A share of common stock.
[F4]The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.

Signature

/s/ Isela Cervantes Rodriguez, as Attorney-in-Fact, for William D. Donovan|2026-04-28

2 files